EF
PBYI icon

Empowered Funds’s Puma Biotechnology PBYI Stock Holding History

Empowered Funds’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Buy
220,316
+16,275
+8% +$119K 0.01% 1243
2026
Q1 		$1.3M Buy
204,041
+17,856
+10% +$115K 0.01% 1304
2025
Q4 		$1.11M Buy
186,185
+66,624
+56% +$354K 0.02% 624
2025
Q3 		$635K Buy
119,561
+81,269
+212% +$345K 0.01% 1321
2025
Q2 		$131K Buy
+38,292
New +$122K ﹤0.01% 1693

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's PBYI Position: Q2 2026 in Review

Empowered Funds increased its Puma Biotechnology (PBYI) stake by 8% in Q2 2026, buying an estimated $119K and bringing the position to 220,316 shares worth $1.79M. The position accounts for 0.01% of the portfolio, ranked #1243.

Empowered Funds first reported a position in PBYI in Q2 2025 and has held it in 5 quarters since. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Empowered Funds held 220,316 shares of Puma Biotechnology worth $1.79M as of Q2 2026.
  • Empowered Funds bought 16,275 Puma Biotechnology shares in Q2 2026, an estimated $119K.
  • Puma Biotechnology made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1243 holding.
  • Empowered Funds first reported a position in Puma Biotechnology in Q2 2025 and has held it in 5 quarters since.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.